Quality Improvement in Heart Failure: A Randomized Educational Intervention to Change Provider Behavior

Congestive Heart Failure

Volumn 18, Issue 5, 2012, Pages 245-253

  Piña, Ileana L ^a   Bruckman, David ^b   Lance, Craig ^c   Hitch, Jeanne ^b   Gee, Julie ^d   Schaub, Kimberley ^d   Davidson, Michelle ^d   Ober, Scott ^d   Aron, David ^d  

^a MONTEFIORE MEDICAL CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^d LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FUROSEMIDE; LOOP DIURETIC AGENT; METOPROLOL; VALSARTAN;

AGED; ARTICLE; CARDIAC PATIENT; CONTROLLED STUDY; DIURETIC THERAPY; DRUG DOSE REDUCTION; EDUCATION PROGRAM; FEMALE; HEALTH CARE QUALITY; HEART EJECTION FRACTION; HEART FAILURE; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL EDUCATION; MEDICAL SPECIALIST; PHYSICIAN; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADRENERGIC BETA-ANTAGONISTS; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; CLINICAL COMPETENCE; CONFIDENCE INTERVALS; EDUCATIONAL STATUS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEART FAILURE; HUMANS; MALE; ODDS RATIO; PHYSICIAN'S PRACTICE PATTERNS; QUALITY OF HEALTH CARE; STATISTICS AS TOPIC;

EID: 84866530754     PISSN: 15275299     EISSN: 17517133     Source Type: Journal    
DOI: 10.1111/j.1751-7133.2012.00300.x     Document Type: Article

References (33)

1. Lloyd-Jones D, Adams RJ, Brown TM, et al. Heart disease and stroke statistics - 2010 update: a report from the American Heart Association. Circulation. 2010;121:e46-e215.
2. Fang J, Mensah GA, Croft JB, Keenan NL. Heart failure-related hospitalization in the U.S., 1979 to 2004. J Am Coll Cardiol. 2008;52:428-34.
3. Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med. 2009;360:1418-28.
4. Krumholz HM, Parent EM, Tu N, et al. Readmission after hospitalization for congestive heart failure among Medicare beneficiaries. Arch Intern Med. 1997;157:99-104.
5. Dunlay SM, Redfield MM, Weston SA, et al. Hospitalizations after heart failure diagnosis a community perspective. J Am Coll Cardiol. 2009;54:1695-702.
6. Muzzarelli S, Leibundgut G, Maeder MT, et al. Predictors of early readmission or death in elderly patients with heart failure. Am Heart J. 2010;160:308-14.
7. Rosamond W, Flegal K, Friday G, et al. Heart disease and stroke statistics - 2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2007;115:e69-171.
8. Hunt SA, Abraham WT, Chin MH, et al. Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2009;119:e391-e479.
9. Lindenfeld J, Albert NM, Boehmer JP, et al. HFSA 2010 comprehensive heart failure practice guideline. J Card Fail. 2010;16:e1-194.
10. Havranek EP, Masoudi FA, Ralston DL, et al. Future challenges in quality improvement in heart failure. Congest Heart Fail. 2002;8:342-45.
11. Krumholz HM, Baker DW, Ashton CM, et al. Evaluating quality of care for patients with heart failure. Circulation. 2000;101:E122-E140.
12. Hobbs FD, Jones MI, Allan TF, et al. European survey of primary care physician perceptions on heart failure diagnosis and management (Euro-HF). Eur Heart J. 2000;21:1877-87.
13. Hobbs FD. Management of heart failure: evidence versus practice. Does current prescribing provide optimal treatment for heart failure patients? Br J Gen Pract. 2000;50:735-42.
14. Gheorghiade M, Gattis WA, O'Connor CM. Treatment gaps in the pharmacologic management of heart failure. Rev Cardiovasc Med. 2002;3(suppl 3):S11-S19.
15. Hjalmarson A, Goldstein S, Fagerberg B, et al. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group. JAMA. 2000;283:1295-302.
16. Packer M, Fowler MB, Roecker EB, et al. Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study. Circulation. 2002;106:2194-99.
17. Fonarow GC. Pharmacologic therapies for acutely decompensated heart failure. Rev Cardiovasc Med. 2002;3(suppl 4):S18-S27.
18. Jong P, Vowinckel E, Liu PP, et al. Prognosis and determinants of survival in patients newly hospitalized for heart failure: a population-based study. Arch Intern Med. 2002;162:1689-94.
19. Bero LA, Grilli R, Grimshaw JM, et al. Closing the gap between research and practice: an overview of systematic reviews of interventions to promote the implementation of research findings. The Cochrane Effective Practice and Organization of Care Review Group. BMJ. 1998;317:465-68.
20. Oxman AD, Thomson MA, Davis DA, Haynes RB. No magic bullets: a systematic review of 102 trials of interventions to improve professional practice. CMAJ. 1995;153:1423-31.
21. Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation. 2005;112:e154-e235.
22. Weingarten S, Riedinger M, Conner L, et al. Reducing lengths of stay in the coronary care unit with a practice guideline for patients with congestive heart failure. Insights from a controlled clinical trial. Med Care. 1994;32:1232-43.
23. Ventura HO, Pina IL. The AHF SCENE II Preceptorship Program: rationale and design of an educational program to optimize management of advanced heart failure. Congest Heart Fail. 2000;6:319-24.
24. Agresti A. Categorical Data Analysis. 2nd ed. Hoboken, NJ: John Wiley & Sons, Inc.; 2002.
25. Stokes ME, Davis CS, Koch GG. Categorical Data Analysis Using the SAS System, + Categorical Data Analysis. 2nd ed. Cary, NC: SAS Institute, Inc.; 2000.
26. Littell RC, Milliken GA, Stroup WW, Wolfinger RD, Schobenberger O. SAS for Mixed Models. 2nd ed. Cary, NC: SAS Institute, Inc.; 2006.
27. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators. N Engl J Med. 1991;325:293-302.
28. Cohn JN, Tognoni G. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med. 2001;345:1667-75.
29. Cabana MD, Rand CS, Powe NR, et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999;282:1458-65.
30. Fuat A, Hungin AP, Murphy JJ. Barriers to accurate diagnosis and effective management of heart failure in primary care: qualitative study. BMJ. 2003;326:196.
31. Fuat A. Bridging the treatment gap: the primary care perspective. Heart. 2005;91(suppl 2):ii35-ii38.
32. Soumerai SB, Avorn J. Principles of educational outreach ('academic detailing') to improve clinical decision making. JAMA. 1990;263:549-56.
33. Soumerai SB, Avorn J. Predictors of physician prescribing change in an educational experiment to improve medication use. Med Care. 1987;25:210-221.